These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 30910538)

  • 21. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification.
    Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K
    Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
    Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
    Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma.
    Chen Z; Pu L; Gao W; Zhang L; Han G; Zhu Q; Li X; Wu J; Wang X
    Oncotarget; 2017 Apr; 8(17):28959-28970. PubMed ID: 28415824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.
    Utada M; Ohno Y; Tamaki T; Sobue T; Endo G
    J Epidemiol; 2014; 24(3):193-9. PubMed ID: 24614916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiological trends of biliary tract cancers in the United States of America.
    Jiang Y; Jiang L; Li F; Li Q; Yuan S; Huang S; Fu Y; Yan X; Chen J; Li H; Li S; Liu J
    BMC Gastroenterol; 2022 Dec; 22(1):546. PubMed ID: 36581813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
    Van Dyke AL; Shiels MS; Jones GS; Pfeiffer RM; Petrick JL; Beebe-Dimmer JL; Koshiol J
    Cancer; 2019 May; 125(9):1489-1498. PubMed ID: 30645774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a genomic predictive model for cholangiocarcinoma using copy number alteration data.
    Tavares I; Martins R; Ribeiro IP; Esteves L; Caramelo F; Abrantes AM; Neves R; Caetano-Oliveira R; Botelho MF; Barbosa de Melo J; Diogo D; Tralhão JG; Carreira IM
    J Clin Pathol; 2022 Apr; 75(4):274-278. PubMed ID: 33649143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.
    Mukkamalla SKR; Naseri HM; Kim BM; Katz SC; Armenio VA
    J Natl Compr Canc Netw; 2018 Apr; 16(4):370-376. PubMed ID: 29632056
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
    Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
    Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
    Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA
    Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
    Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
    BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrahepatic cholangiocarcinoma: current surgical strategy.
    Boutros C; Somasundar P; Espat NJ
    Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.
    Spencer K; Pappas L; Baiev I; Maurer J; Bocobo AG; Zhang K; Jain A; De Armas AD; Reyes S; Le TM; Rahma OE; Stanton J; DeLeon TT; Roth M; Peters MLB; Zhu AX; Lennerz JK; Iafrate AJ; Boyhen K; VanCott C; Roberts LR; Lindsey S; Horick N; Goff LW; Mody K; Borad MJ; Shroff RT; Kelley RK; Javle MM; Goyal L
    J Natl Cancer Inst; 2023 Jul; 115(7):870-880. PubMed ID: 37040087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Case-control study of risk factors in cholangiocarcinoma].
    Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
    Chaudhary HB; Bhanot P; Logroño R
    Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor Budding in Intrahepatic Cholangiocarcinoma: A Predictor of Postsurgery Outcomes.
    Tanaka M; Yamauchi N; Ushiku T; Shibahara J; Hayashi A; Misumi K; Yasunaga Y; Morikawa T; Kokudo T; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
    Am J Surg Pathol; 2019 Sep; 43(9):1180-1190. PubMed ID: 31335353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
    Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
    Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.
    Jing W; Jin G; Zhou X; Zhou Y; Zhang Y; Shao C; Liu R; Hu X
    Eur J Cancer Prev; 2012 Jan; 21(1):24-31. PubMed ID: 21857525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.